James M. McKiernan, MD
James M. McKiernan, MD
One of America's Top Doctors - Castle Connolly Top Doctors
Rated one of New York Magazine's Best Doctors

James M. McKiernan, MD

Urology
phone icon
phone icon
One of America's Top Doctors - Castle Connolly Top Doctors
Rated one of New York Magazine's Best Doctors
Specialties
Urology, Cancer Care, Urologic Oncology, more

Locations and Appointments


New Patients
Virtual Visits

CUIMC/Herbert Irving Pavilion

161 Fort Washington Avenue
New York, NY 10032
US
Call to ScheduleNew and Existing Patients
Existing Patients
Login or sign-up to Connect Patient Portal to make an appointment

ColumbiaDoctors - 500 Grand Avenue

500 Grand Avenue
Englewood, NJ 07631
US
Call to ScheduleNew and Existing Patients
Existing Patients
Login or sign-up to Connect Patient Portal to make an appointment
Existing Patients
Login to Connect Patient Portal make an appointment, view documentation or contact your doctor’s office.
NYP Connect App
The NYP Connect App allows you to access convenient services to help manage your health. Access the patient portal, communicate with your doctor, manage appointments, view test results, request prescription refills, pay a bill, and find a doctor.

insurance icon
Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

  • AETNA
  • Affinity Health Plan
  • AgeWell
  • Amida Care
  • CIGNA
  • Emblem/GHI
  • Emblem/Hip
  • Empire Blue Cross Blue Shield Healthplus
  • Empire Blue Cross/Blue Shield
  • Fidelis Care
  • Healthfirst
  • Local 1199
  • Magnacare (National)
  • Medicare
  • Multiplan
  • MVP Health Care
  • Quality Health Management
  • RiverSpring
  • UnitedHealthcare
  • VNSNY CHOICE
  • WellCare
  • World Trade Center Health Plan

about icon
About James M. McKiernan, MD

James McKiernan, MD, the John K. Lattimer Professor of Urology, is the chair of the Department of Urology of the College of Physicians and Surgeons and urologist-in-chief at NewYork-Presbyterian/Columbia. Dr. McKiernan is only the sixth physician to hold this title since the founding of the department in 1917. The Department of Urology, one of the oldest and most distinguished in the nation, consistently ranks among the top in New York and throughout the United States. NewYork-Presbyterian's urology program ranked No. 5 in the latest U.S. News & World Report ranking of America's best hospitals. In 2015, the department ranked No. 7 in NIH grant funding among academic Urology departments in America.


Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues.


For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.


Board Certifications

  • Urology
list icon

Expertise

  • Adrenal Cancer

  • Bladder Cancer

  • Bladder Tumor

  • Genitourinary Surgery

  • Kidney Cancer

  • Major Bladder Reconstruction

  • Prostate Cancer

  • Testicular Cancer

  • Urologic Cancer

list icon

Education

  • Fellowship: Memorial Sloan-Kettering Cancer Center, NY

  • Medical School: Columbia University College of Physicians and Surgeons

  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

list icon

Titles & Positions

  • Chair, Department of Urology

  • Director, Urologic Oncology

  • John K. Lattimer Professor of Urology

list icon

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Education

  • Fellowship: Memorial Sloan-Kettering Cancer Center, NY
  • Medical School: Columbia University College of Physicians and Surgeons
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center

Titles & Positions

  • Chair, Department of Urology
  • Director, Urologic Oncology
  • John K. Lattimer Professor of Urology

Board Certifications

  • Urology

Languages Spoken

  • Spanish